Old Web
English
Sign In
Acemap
>
authorDetail
>
Asuki Fukatsu
Asuki Fukatsu
Nagoya University
Oncology
Internal medicine
Medicine
Lung cancer
Pathology
4
Papers
57
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
PREDICT1: An observational study for identifying blood biomarkers associated with clinical benefit from carboplatin and pemetrexed (CbP) treatment in patients with non-squamous (NS) non-small cell lung cancer (NSCLC) (CJLSG1201).
2020
Journal of Clinical Oncology
Tetsunari Hase
Kiyoshi Yanagisawa
Asuki Fukatsu
Tomoki Kimura
Eiji Kojima
Takashi Abe
Kazuyoshi Imaizumi
Yoshitsugu Horio
Tetsuya Oguri
Masashi Yamamoto
Tomohiko Ogasawara
Yasuteru Sugino
Masahiro Morise
Masahiro Nakatochi
Masahiko Ando
Masashi Kondo
Hideo Saka
Hiroshi Saito
Yoshinori Hasegawa
Takashi Takahashi
Show All
Source
Cite
Save
Citations (0)
A phase II trial of Ifosfamide combination with recommended supportive therapy for recurrent SCLC in second-line and heavily treated setting
2018
Cancer Chemotherapy and Pharmacology
Ichidai Tanaka
Kenji Kawada
Masahiro Morise
Tetsunari Hase
Hiroaki Hayashi
Akihiko Sokai
Asuki Fukatsu
Masashi Kondo
Fumio Nomura
Yoshinori Hasegawa
Show All
Source
Cite
Save
Citations (2)
LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade
2015
Oncogene
Ichidai Tanaka
Hirotaka Osada
Makiko Fujii
Asuki Fukatsu
Toyoaki Hida
Yoshitsugu Horio
Yutaka Kondo
Ayuko Sato
Yoshinori Hasegawa
Tohru Tsujimura
Yoshitaka Sekido
Show All
Source
Cite
Save
Citations (46)
RASSF3 downregulation increases malignant phenotypes of non-small cell lung cancer
2014
Lung Cancer
Asuki Fukatsu
Futoshi Ishiguro
Ichidai Tanaka
Takumi Kudo
Kentaro Nakagawa
Keiko Shinjo
Yutaka Kondo
Makiko Fujii
Yoshinori Hasegawa
Kenji Tomizawa
Tetsuya Mitsudomi
Hirotaka Osada
Yutaka Hata
Yoshitaka Sekido
Show All
Source
Cite
Save
Citations (9)
1
map